Will DXCM's G7 Uptake Continue to Drive Top-line Growth in Q1? [Yahoo! Finance]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Yahoo! Finance
In the last reported quarter, the company's adjusted earnings per share (EPS) of 68 cents surpassed the Zacks Consensus Estimate by 4.62%. Let us check out the factors that might have shaped DXCM's performance prior to the announcement. DXCM's Q1 Estimates The Zacks Consensus Estimate for revenues is pegged at $1.18 billion, indicating an increase of 13.6% from the prior-year quarter's level. The consensus mark for earnings is pinned at 47 cents, indicating growth 46.9% year over year. For the first quarter of 2026, DexCom expects sustained strong sensor uptake, building on fourth-quarter momentum and reflecting stable utilization despite intensifying competition. Factors to Note Before DXCM's Q1 Earnings Report DexCom's upcoming quarterly results are expected to reflect continued solid growth, supported by strong demand for continuous glucose monitoring (CGM) devices and ongoing product innovation, though unfavorable mix and investment pressures may weigh on margins. T
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- Forget Ozempic: This High-Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins [Yahoo! Finance]Yahoo! Finance
- Baird Small/Mid Cap Growth Q1 2026 Commentary [Seeking Alpha]Seeking Alpha
- DXCM STOCKHOLDER NOTICE: Kaskela Law Firm Announces Stockholder Investigation of DexCom, Inc. (DXCM) and Encourages Long-Term DXCM Investors to Contact the FirmGlobeNewswire
- A Look At Dexcom (DXCM) Valuation As Shares Lag And Fair Value Estimates Point Higher [Yahoo! Finance]Yahoo! Finance
- Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
DXCM
Earnings
- 2/12/26 - Beat
DXCM
Sec Filings
- 4/16/26 - Form 4
- 4/15/26 - Form ARS
- 4/15/26 - Form DEFA14A
- DXCM's page on the SEC website